Emergent Product Development Seattle, LLC
Records under this name other than patents Emergent Product Development Seattle, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Emergent Product Development Seattle, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,333,966 | CD37 Immunotherapeutics and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,101,609 | CD37 Immunotherapeutic and Combination with Bifunctional Chemotherapeutic Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,409,577 | Single-Chain Multivalent Binding Proteins with Effector Function Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,307,481 | CD37 Immunotherapeutics and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,202,452 | CD3 Binding Polypeptides Formerly held Lapsed on the fee record Ended Feb 12, 2023 · High confidence | Lapsed on the fee record | Ended Feb 12, 2023 | High confidence |
| US 7,846,434 | Materials and Methods for Improved Immunoglycoproteins Formerly held Lapsed on the fee record Ended Dec 7, 2022 · Medium confidence | Lapsed on the fee record | Ended Dec 7, 2022 | Medium confidence |
| US 10,143,748 | B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules Lapsed on the fee record Ended Dec 4, 2022 · High confidence | Lapsed on the fee record | Ended Dec 4, 2022 | High confidence |
| US 7,829,084 | Binding Constructs and Methods for Use Thereof Formerly held Lapsed on the fee record Ended Nov 9, 2022 · Medium confidence | Lapsed on the fee record | Ended Nov 9, 2022 | Medium confidence |
| US 8,853,366 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Term ended Term ended Feb 12, 2022 · Medium confidence | Term ended | Term ended Feb 12, 2022 | Medium confidence |
| US 9,005,612 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Term ended Term ended Jan 17, 2022 · Medium confidence | Term ended | Term ended Jan 17, 2022 | Medium confidence |